A Phase II, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patient With Active Rheumatoid Arthritis
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009255/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-group, multicenter
study enrolling patients with active rheumatoid arthritis (RA).
提供机构：
Vivli
创建时间：
2023-09-12
